메뉴 건너뛰기




Volumn 3, Issue 2, 2012, Pages 195-202

MiR-181b: New perspective to evaluate disease progression in chronic lymphocytic leukemia

Author keywords

CLL; Diagnosis; MiR 181b

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; MICRORNA; MICRORNA 181B; PROTEIN KINASE ZAP 70; UNCLASSIFIED DRUG; MIRN181 MICRORNA, HUMAN; TUMOR MARKER;

EID: 84863793421     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (45)

References (33)
  • 1
    • 0034649716 scopus 로고    scopus 로고
    • When and how to treat chronic lymphocytic leukemia
    • Dighiero G and Binet JL. When and how to treat chronic lymphocytic leukemia. N Engl J Med. 2000; 343:1799-1801.
    • (2000) N Engl J Med , vol.343 , pp. 1799-1801
    • Dighiero, G.1    Binet, J.L.2
  • 3
    • 0029981025 scopus 로고    scopus 로고
    • National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia, revised guidelines for diagnosis and treatment
    • Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S and Rai KR. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996; 87:4990-4997.
    • (1996) Blood , vol.87 , pp. 4990-4997
    • Cheson, B.D.1    Bennett, J.M.2    Grever, M.3    Kay, N.4    Keating, M.J.5    O'Brien, S.6    Rai, K.R.7
  • 8
    • 0345593600 scopus 로고    scopus 로고
    • 2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia
    • Robak T, Blasinska-Morawiec M, Blonski JZ and Dmoszynska A. 2-Chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia. Leuk Lymphoma. 1999; 34:151-157.
    • (1999) Leuk Lymphoma , vol.34 , pp. 151-157
    • Robak, T.1    Blasinska-Morawiec, M.2    Blonski, J.Z.3    Dmoszynska, A.4
  • 9
    • 79957984650 scopus 로고    scopus 로고
    • Refractory chronic lymphocytic leukemia-new therapeutic strategies
    • Schnaiter A and Stilgenbauer S. Refractory chronic lymphocytic leukemia-new therapeutic strategies. Oncotarget. 2010; 1:472-482.
    • (2010) Oncotarget , vol.1 , pp. 472-482
    • Schnaiter, A.1    Stilgenbauer, S.2
  • 10
    • 84858415416 scopus 로고    scopus 로고
    • Phosphoinositide 3'-kinase delta, turning off BCR signaling in Chronic Lymphocytic Leukemia
    • Burger JA and Hoellenriegel J. Phosphoinositide 3'-kinase delta: turning off BCR signaling in Chronic Lymphocytic Leukemia. Oncotarget. 2011; 2:737-738.
    • (2011) Oncotarget , vol.2 , pp. 737-738
    • Burger, J.A.1    Hoellenriegel, J.2
  • 11
    • 79954997822 scopus 로고    scopus 로고
    • Prognostic markers and stratification of chronic lymphocytic leukemia
    • Furman RR. Prognostic markers and stratification of chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2010; 2010:77-81.
    • (2010) Hematology Am Soc Hematol Educ Program , vol.2010 , pp. 77-81
    • Furman, R.R.1
  • 12
    • 0036464608 scopus 로고    scopus 로고
    • CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease
    • Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK and Oscier DG. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood. 2002; 99:1023-1029.
    • (2002) Blood , vol.99 , pp. 1023-1029
    • Hamblin, T.J.1    Orchard, J.A.2    Ibbotson, R.E.3    Davis, Z.4    Thomas, P.W.5    Stevenson, F.K.6    Oscier, D.G.7
  • 13
    • 65349117527 scopus 로고    scopus 로고
    • MiRNAs and cancer
    • Visone R and Croce CM. MiRNAs and cancer. Am J Pathol. 2009; 174:1131-1138.
    • (2009) Am J Pathol , vol.174 , pp. 1131-1138
    • Visone, R.1    Croce, C.M.2
  • 18
  • 21
    • 79955070135 scopus 로고    scopus 로고
    • Is miR-29 an oncogene or tumor suppressor in CLL?
    • Pekarsky Y and Croce CM. Is miR-29 an oncogene or tumor suppressor in CLL? Oncotarget. 2010; 1:224-227.
    • (2010) Oncotarget , vol.1 , pp. 224-227
    • Pekarsky, Y.1    Croce, C.M.2
  • 30
    • 33645991529 scopus 로고    scopus 로고
    • Risk stratification in chronic lymphocytic leukemia
    • Seiler T, Dohner H and Stilgenbauer S. Risk stratification in chronic lymphocytic leukemia. Semin Oncol. 2006; 33:186-194.
    • (2006) Semin Oncol , vol.33 , pp. 186-194
    • Seiler, T.1    Dohner, H.2    Stilgenbauer, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.